BIO Capital Expenditure
Bio-Rad Laboratories, Inc. Class A Common Stock · Capital Expenditure
BIO Capital Expenditure
Latest reported-$139.50Mperiod ending
BIO CapEx (-$13.40M → -$139.50M)
Annual CapEx
High-resolution chart · PNG
BIO capital expenditure history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -157,600,000 | |
| -189,000,000 | |
| -156,680,000 | |
| -114,157,000 | |
| -133,746,000 | |
| -108,564,000 | |
| -98,532,000 | |
| -129,828,000 | |
| -115,127,000 | |
| -141,571,000 | |
| -113,372,000 | |
| -136,478,000 | |
| -107,358,000 | |
| -144,649,000 | |
| -103,324,000 | |
| -92,534,000 | |
| -76,361,000 | |
| -88,809,000 | |
| -62,670,000 | |
| -52,987,000 | |
| -36,055,000 | |
| -60,493,000 | |
| -69,003,000 | |
| -42,224,000 | |
| -43,228,000 | |
| -31,406,000 | |
| -230,100,000 | |
| -21,200,000 | |
| -54,800,000 | |
| -15,200,000 | |
| -12,300,000 | |
| -9,800,000 | |
| -14,500,000 | |
| -20,400,000 | |
| -31,000,000 | |
| -13,400,000 | |
| -13,400,000 |